source
- Takeda's plaque psoriasis pill beats Bristol Myers' Sotyktu in Phase 3Takeda’s $4 billion bet on an oral plaque psoriasis drug has paid off again, as the company reported the pill beat Bristol Myers Squibb’s Sotyktu in a head-to-head Phase 3 study. Zasocitinib induce…Endpoints · 1mo ago↗ source
- Neion Bio raises $23M Series A to make proteins from chicken eggsNeion Bio has secured an oversubscribed $23 million Series A to further develop its technology that uses chicken eggs to make active pharmaceutical ingredients for biologic drugs. The funding round…Endpoints · 1mo ago↗ source
- Opinion: We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850In 2025, Elizabeth Selvin and her colleagues published in Nature Medicine for free. In 2026, it cost them $12,850, she writes.